Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors

Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on lowering blood glucose levels effectively via increasing the glomerular excretion of gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Thani, Najlaa A., Hasan, Maram, Yalcin, Huseyin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615955/
https://www.ncbi.nlm.nih.gov/pubmed/37052784
http://dx.doi.org/10.1007/s12265-023-10379-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615955/
https://www.ncbi.nlm.nih.gov/pubmed/37052784
http://dx.doi.org/10.1007/s12265-023-10379-5

Ejemplares similares